Purpose: The EU COST Action 15111 collaboration on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) aims to assess current research and identify knowledge gaps in Europe. Presently, our purpose is to map the effects of non-pharmacological therapies (NPTs) for ME/CFS, and what patients find important in the treatment process. Methods: A scoping mixed methods literature review of European studies identified 16 papers fulfiling our inclusion criteria. The quantitative and qualitative studies were synthesized separately in tables. Additionally, extracts from the qualitative studies were subjected to translational analysis. Results: Effect studies addressed cognitive behavioural therapy (CBT, n = 4), multimodal rehabilitation (n =...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.This collection of res...
The EU COST Action 15111 collaboration on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS...
The EU COST Action 15111 collaboration on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS...
Purpose: The pathogenesis of chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is comp...
ME/CFS is a chronic, complex, multisystem disease that often limits the health and functioning of th...
The PACE trial was a four-arm trial of specialist medical care, compared with specialist medical car...
ME/CFS is a chronic, complex, multisystem disease that often limits the health and functioning of th...
Background: Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue syn...
Background: Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue syn...
syndrome (CFS) is a debilitating multisystem condition affecting more than 1 million adults in the U...
Background Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue synd...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Background Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue syn...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.This collection of res...
The EU COST Action 15111 collaboration on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS...
The EU COST Action 15111 collaboration on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS...
Purpose: The pathogenesis of chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is comp...
ME/CFS is a chronic, complex, multisystem disease that often limits the health and functioning of th...
The PACE trial was a four-arm trial of specialist medical care, compared with specialist medical car...
ME/CFS is a chronic, complex, multisystem disease that often limits the health and functioning of th...
Background: Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue syn...
Background: Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue syn...
syndrome (CFS) is a debilitating multisystem condition affecting more than 1 million adults in the U...
Background Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue synd...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Background Controversy over treatment for people with myalgic encephalomyelitis/chronic fatigue syn...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of un...
Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.This collection of res...